Mike Crapo said...

When we talk about the need for greater transparency in the drug supply chain, that term can and should mean a few diffe...

We need to identify avenues for lowering out-of-pocket costs, increasing competition, and promoting access to lifesaving...

Congress took a critical step toward addressing these challenges nearly 20 years ago, when we voted to enact Medicare's ...

I have long championed efforts to improve prescription drug access and affordability for Americans, and I welcome the op...